Dystrophia myotonica: a multisystem disease.
D000758:Anesthesia; D001285:Atropine / Q000627:therapeutic use; D002802:Cholinesterases / Q000097:blood; D004576:Electromyography; D006221:Halothane / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008545:Melanoma / Q000601:surgery; D008875:Middle Aged; D009135:Muscular Diseases / Q000601:surgery; D009222:Myotonia / Q000145:classification / Q000503:physiopathology; D009224:Myotonia Congenita / Q000503:physiopathology; D009223:Myotonic Dystrophy / Q000097:blood / Q000188:drug therapy / Q000201:enzymology / Q000503:physiopathology; D009369:Neoplasms / Q000601:surgery; D009388:Neostigmine / Q000627:therapeutic use; D010197:Pancuronium / Q000627:therapeutic use; D011229:Preanesthetic Medication; D013053:Spectrophotometry; D013390:Succinylcholine / Q000627:therapeutic use; D013696:Temperature; D013997:Time Factors
D009388:Neostigmine; D001285:Atropine; D002802:Cholinesterases; D013390:Succinylcholine; D010197:Pancuronium; D006221:Halothane